文献速递甲状腺与颈部外科

甲状腺髓样癌再手术与疾病特异性死亡的危险因素

Risk Factors Associated With Reoperation and Disease-Specific Mortality in Patients With Medullary Thyroid Carcinoma.
PubMed 文献 · JAMA Surg · 2018-01-01

基于加州癌症登记处1999至2012年数据,纳入609例接受甲状腺手术且随访≥2年的甲状腺髓样癌患者进行回顾分析。初诊时仅35.5%行中央区颈清扫,再手术率16.3%;淋巴结转移增加再手术风险,初始中央区和侧颈清扫具保护作用;再手术未增加死亡风险。

要点

  • 淋巴结转移增加再手术风险(HR 3.43),初始中央区和侧颈清扫具保护作用(HR 0.53)。
  • 初诊时中央区颈清扫使用不足,仅35.5%患者接受。
  • 再手术未与死亡率升高相关,是合适患者实现长期无病生存的可行策略。

核心结论

  • 淋巴结清扫可能减少甲状腺髓样癌患者因复发导致的再手术。
  • 对合适选择的患者,再手术是实现长期无病生存的可行策略。
  • 中央区颈清扫在初诊手术中仍使用不足。

研究设计与样本

  • 回顾性分析加州癌症登记处与全州健康规划与发展办公室1999年1月1日至2012年12月31日医院数据。
  • 共识别953例甲状腺髓样癌患者,纳入接受甲状腺手术且术后随访至少2年的609例进行分析。
  • 暴露因素为甲状腺髓样癌初始颈清扫,主要结局为复发导致再手术和疾病特异性死亡。

主要发现

  • 609例患者诊断时平均(SD)年龄52.6(17.5)岁,女性占60.8%(370例),平均(SD)肿瘤大小2.8(2.0)cm。
  • 初诊时仅35.5%(216/609)行中央区颈清扫,再手术率16.3%(99/609),再手术中位时间6.4个月。
  • 淋巴结转移增加再手术风险(HR 3.43;95%CI 2.00-5.90),初始中央区和侧颈清扫具保护作用(HR 0.53;95%CI 0.30-0.93)。
  • 再手术患者中45.5%(45/99)在中位随访7.7年时无病生存,全队列5年疾病特异性死亡率为13.5%(82/609)。
  • 疾病特异性死亡的独立危险因素包括年龄较大(每十年HR 1.36;95%CI 1.17-1.59)、肿瘤大于2cm(>2至4cm HR 2.83;95%CI 1.08-7.44;>4cm HR 2.89;95%CI 1.09-7.71)、区域病变(HR 4.77;95%CI 2.29-9.94)和转移病变(HR 21.08;95%CI 9.90-44.89),再手术未与死亡率升高相关。

关键数值与推荐

  • 已发表甲状腺髓样癌指南推荐初始中央区颈清扫,但本队列仅35.5%(216/609)在初始甲状腺切除术时接受中央区颈清扫。
  • 再手术率16.3%(99/609),再手术中位时间6.4个月。
  • 全队列5年疾病特异性死亡率为13.5%(82/609)。

临床怎么用

  • 对甲状腺髓样癌患者应重视初始中央区颈清扫,以降低复发导致再手术的风险。
  • 对合适选择的复发患者,再手术可考虑用于实现长期无病生存。
  • 年龄较大、肿瘤大于2cm、区域或转移病变提示疾病特异性死亡风险较高,需加强随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The association of initial neck dissection with recurrence in medullary thyroid carcinoma (MTC) has not been evaluated on a population level to date. OBJECTIVE: To elucidate risk factors associated with reoperation in MTC and disease-specific mortality. DESIGN, SETTING, AND PARTICIPANTS: A retrospective analysis was performed of hospital data obtained from the California Cancer Registry and the Office of Statewide Health Planning and Development from January 1, 1999, through December 31, 2012. The dates of the analysis were January 1, 1999, to December 31, 2012. A population-based sample of 953 patients with MTC was identified. Patients who underwent thyroid surgery and had a minimum postoperative follow-up of 2 years (n = 609) were included in the analysis. EXPOSURE: Initial neck dissection in MTC. MAIN OUTCOMES AND MEASURES: Recurrent MTC leading to reoperation and disease-specific mortality. RESULTS: Of the 609 patients with MTC who underwent thyroid surgery, the mean (SD) patient age at diagnosis was 52.6 (17.5) years, and 60.8% (n = 370) of the patients were female. The mean (SD) tumor size was 2.8 (2.0) cm. Although initial central neck dissection is recommended by published MTC guidelines, only 35.5% (216 of 609) of patients underwent central neck dissection at the time of the initial thyroidectomy. The rate of reoperation was 16.3% (99 of 609), and the median time to reoperation was 6.4 months. The presence of lymph node metastasis increased the risk of reoperation (hazard ratio [HR], 3.43; 95% CI, 2.00-5.90), while central and lateral neck dissection performed at the initial operation was protective (HR, 0.53; 95% CI, 0.30-0.93). In patients who underwent reoperation, 45.5% (45 of 99) were disease free at a median follow-up of 7.7 years. Five-year disease-specific mortality for the entire cohort was 13.5% (82 of 609). Independent risk factors for disease-specific mortality included older age (HR, 1.36 per decade; 95% CI, 1.17-1.59), tumor size greater than 2 cm (HR, 2.83; 95% CI, 1.08-7.44 for >2 to 4 cm and HR, 2.89; 95% CI, 1.09-7.71 for >4 cm), and regional (HR, 4.77; 95% CI, 2.29-9.94) and metastatic (HR, 21.08; 95% CI, 9.90-44.89) disease. Reoperation was not associated with increased mortality. CONCLUSIONS AND RELEVANCE: Lymph node dissection may decrease recurrence leading to reoperation for patients with MTC. Reoperation is a viable strategy to achieve long-term disease-free survival in appropriately selected patients. Central neck dissection remains underused.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Kuo EJ, Sho S, Li N, et al. Risk Factors Associated With Reoperation and Disease-Specific Mortality in Patients With Medullary Thyroid Carcinoma. JAMA Surg. 2018. PMID: 28973144. doi:10.1001/jamasurg.2017.3555

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。